Riskpilot← Back to searchSign inGet full accessKLINIKK PLUSS AS
ASActiveOrg 936565603Løkketangen 10A, 1337 SandvikaPhysiotherapy activities · NACE 8695Est. 19845 employeeswww.klinikkpluss.no
Revenue 2025
NOK 13,1M
-4% vs 2024
EBITDA margin
1.0%
-67% vs 2024
Equity ratio
66.9%
Financial strength
Net profit 2025
NOK 104K
-67% vs 2024
| Revenue | NOK 13,1M | -4% |
| EBITDA | NOK 135K | -67% |
| Net profit | NOK 104K | -67% |
| Total assets | NOK 3,1M | -5% |
| Equity | NOK 2M | -4% |
| Employees | 5 | — |
Legal name
KLINIKK PLUSS AS
Org number
936565603
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
18. oktober 1984
Share capital
NOK 766 276
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap. Daglig leder og styrets leder i fellesskap.
Company purpose
Å være en moderne tverrfaglig helseklinikk, med spisskompetanse innen muskel-, skjelett- og nervebaserte lidelser. Vi tilbyr et bredt utvalg av anerkjente behandlingdformer med hovedvekt på kiropraktikk, fysioterapi og akupunktur.
Address
Løkketangen 10A, 1337 Sandvika
Website
www.klinikkpluss.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 13 571 | 13 644 | 12 546 | 13 707 | 13 097 |
| Staff expenses | −1 369 | −1 367 | −1 160 | −1 511 | −1 481 |
| EBITDA | 650 | −841 | −115 | 410 | 135 |
| Depreciation & amort. | −165 | −68 | −49 | −49 | −49 |
| EBIT | 485 | −909 | −164 | 361 | 86 |
| Net financials | 2 | 4 | 19 | 44 | 44 |
| Profit before tax | 487 | −905 | −145 | 405 | 129 |
| Tax | 108 | −199 | −6 | 89 | 25 |
| Net profit | 380 | −706 | −139 | 316 | 104 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 463 | 3 169 | 2 890 | 3 213 | 3 054 |
| Equity | 2 667 | 1 961 | 1 822 | 2 138 | 2 042 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 797 | 1 209 | 1 068 | 1 076 | 1 012 |
| Total debt | 797 | 1 209 | 1 068 | 1 076 | 1 012 |
EBITDA margin
1.0%
This company
15.8%
Market median
-94% vs market
20212025
Equity ratio
66.9%
This company
38.2%
Market median
+75% vs market
20212025
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
20212025
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20212025
Asset turnover
4.29×
This company
1.12×
Market median
+283% vs market
20212025
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MF Chief Executive Officer | Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2025 | |
| Former (2) | ||
| Board of Directors | 2021 – 2023 | |
| Chairman | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 40.56% | 40.56% | 2024 | |
| Individual | 15.97% | 15.97% | 2022 | |
| Individual | 13.39% | 13.39% | 2022 | |
| Individual | 13.39% | 13.39% | 2024 | |
| Company | 10.62% | 10.62% | 2022 | |
| Company | 10.26% | 10.26% | 2024 | |
| Individual | 10% | 10% | 2024 | |
| Individual | 9.98% | 9.98% | 2024 | |
| Individual | 9.65% | 9.65% | 2024 | |
| Individual | 6.16% | 6.16% | 2024 | |
| Individual | 1.33% | 1.33% | 2022 | |
| Individual | 1.33% | 1.33% | 2022 | |
| Individual | 1.33% | 1.33% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KLINIKK PLUSS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Flatland | Chief Executive Officer | 0 companies |
| Christin Maire Lian | Chairman | 0 companies |
| Kjetil Christiansen Nord-Varhaug | Board of Directors | 0 companies |
| Bjørn Sigurd Bay | Chairman | 0 companies |
| Andreas Stevning | Board of Directors | 0 companies |